

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cerebellar granule cell differentiation (GO:0021707) | 5.38956892 |
| 2 | postsynaptic membrane organization (GO:0001941) | 4.77020339 |
| 3 | presynaptic membrane assembly (GO:0097105) | 4.71419914 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.71204698 |
| 5 | facial nerve structural organization (GO:0021612) | 4.70615882 |
| 6 | exploration behavior (GO:0035640) | 4.57518018 |
| 7 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.28842583 |
| 8 | cellular potassium ion homeostasis (GO:0030007) | 4.19316044 |
| 9 | presynaptic membrane organization (GO:0097090) | 4.16330250 |
| 10 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.14193211 |
| 11 | sodium ion export (GO:0071436) | 4.04017142 |
| 12 | neuronal action potential propagation (GO:0019227) | 4.03534081 |
| 13 | cranial nerve structural organization (GO:0021604) | 4.02301003 |
| 14 | amino acid import (GO:0043090) | 3.96851190 |
| 15 | locomotory exploration behavior (GO:0035641) | 3.88961710 |
| 16 | synaptic vesicle maturation (GO:0016188) | 3.81395301 |
| 17 | behavioral response to nicotine (GO:0035095) | 3.80677008 |
| 18 | potassium ion import (GO:0010107) | 3.75530722 |
| 19 | cranial nerve morphogenesis (GO:0021602) | 3.72292348 |
| 20 | gamma-aminobutyric acid transport (GO:0015812) | 3.68397029 |
| 21 | righting reflex (GO:0060013) | 3.63618414 |
| 22 | neuron cell-cell adhesion (GO:0007158) | 3.61588104 |
| 23 | regulation of synapse structural plasticity (GO:0051823) | 3.55968612 |
| 24 | synaptic vesicle exocytosis (GO:0016079) | 3.54203314 |
| 25 | glutamate secretion (GO:0014047) | 3.53455962 |
| 26 | * neuron-neuron synaptic transmission (GO:0007270) | 3.50209817 |
| 27 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.47176829 |
| 28 | regulation of synaptic vesicle transport (GO:1902803) | 3.45720165 |
| 29 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.45048302 |
| 30 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.43978092 |
| 31 | neuron recognition (GO:0008038) | 3.43729114 |
| 32 | axonal fasciculation (GO:0007413) | 3.39105171 |
| 33 | protein localization to synapse (GO:0035418) | 3.37906344 |
| 34 | neurotransmitter secretion (GO:0007269) | 3.34167451 |
| 35 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.24469441 |
| 36 | omega-hydroxylase P450 pathway (GO:0097267) | 3.24171649 |
| 37 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.21661510 |
| 38 | regulation of pigment cell differentiation (GO:0050932) | 3.19628881 |
| 39 | cochlea development (GO:0090102) | 3.19419405 |
| 40 | membrane depolarization during action potential (GO:0086010) | 3.18025338 |
| 41 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.17168643 |
| 42 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.16031202 |
| 43 | dermatan sulfate biosynthetic process (GO:0030208) | 3.12474219 |
| 44 | cellular sodium ion homeostasis (GO:0006883) | 3.10873389 |
| 45 | prepulse inhibition (GO:0060134) | 3.09962284 |
| 46 | layer formation in cerebral cortex (GO:0021819) | 3.08667596 |
| 47 | vocalization behavior (GO:0071625) | 3.07953582 |
| 48 | protein localization to cilium (GO:0061512) | 3.07559672 |
| 49 | potassium ion homeostasis (GO:0055075) | 3.05489680 |
| 50 | photoreceptor cell differentiation (GO:0046530) | 3.04749111 |
| 51 | eye photoreceptor cell differentiation (GO:0001754) | 3.04749111 |
| 52 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.04536764 |
| 53 | lymphoid progenitor cell differentiation (GO:0002320) | 3.03759772 |
| 54 | positive regulation of synapse maturation (GO:0090129) | 3.03636762 |
| 55 | cell differentiation in hindbrain (GO:0021533) | 3.03125520 |
| 56 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.99948440 |
| 57 | innervation (GO:0060384) | 2.98007991 |
| 58 | nonmotile primary cilium assembly (GO:0035058) | 2.93574389 |
| 59 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.93345434 |
| 60 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.92490130 |
| 61 | membrane depolarization (GO:0051899) | 2.92328678 |
| 62 | establishment of nucleus localization (GO:0040023) | 2.91788117 |
| 63 | regulation of timing of cell differentiation (GO:0048505) | 2.91038050 |
| 64 | neuromuscular process controlling balance (GO:0050885) | 2.88501700 |
| 65 | neurotransmitter transport (GO:0006836) | 2.87453057 |
| 66 | neurotransmitter uptake (GO:0001504) | 2.87063054 |
| 67 | long-term synaptic potentiation (GO:0060291) | 2.85345596 |
| 68 | spinal cord development (GO:0021510) | 2.85236513 |
| 69 | behavioral response to cocaine (GO:0048148) | 2.85125953 |
| 70 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.83821605 |
| 71 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.82405335 |
| 72 | * ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.82309176 |
| 73 | sympathetic nervous system development (GO:0048485) | 2.81919920 |
| 74 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.80689500 |
| 75 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.80689500 |
| 76 | synaptic vesicle endocytosis (GO:0048488) | 2.80165887 |
| 77 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.79924782 |
| 78 | dermatan sulfate metabolic process (GO:0030205) | 2.78812122 |
| 79 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.78519682 |
| 80 | synapse assembly (GO:0007416) | 2.78210051 |
| 81 | retinal cone cell development (GO:0046549) | 2.78140890 |
| 82 | regulation of neurotransmitter transport (GO:0051588) | 2.77759865 |
| 83 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.76912439 |
| 84 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.76912439 |
| 85 | cerebellar Purkinje cell layer development (GO:0021680) | 2.76617629 |
| 86 | mesonephros development (GO:0001823) | 2.76447867 |
| 87 | central nervous system neuron axonogenesis (GO:0021955) | 2.76399525 |
| 88 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.75781734 |
| 89 | positive regulation of dendritic spine development (GO:0060999) | 2.75568775 |
| 90 | regulation of neurotransmitter secretion (GO:0046928) | 2.75458131 |
| 91 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.75191054 |
| 92 | axon ensheathment in central nervous system (GO:0032291) | 2.74868745 |
| 93 | central nervous system myelination (GO:0022010) | 2.74868745 |
| 94 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.74778984 |
| 95 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.72809733 |
| 96 | synapse organization (GO:0050808) | 2.70901500 |
| 97 | startle response (GO:0001964) | 2.70423569 |
| 98 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.69543885 |
| 99 | respiratory chain complex IV assembly (GO:0008535) | 2.63488340 |
| 100 | positive regulation of membrane potential (GO:0045838) | 2.60794926 |
| 101 | cytochrome complex assembly (GO:0017004) | 2.60332969 |
| 102 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.60117822 |
| 103 | positive regulation of synapse assembly (GO:0051965) | 2.58958599 |
| 104 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.58905790 |
| 105 | regulation of development, heterochronic (GO:0040034) | 2.57860856 |
| 106 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.56626522 |
| 107 | auditory behavior (GO:0031223) | 2.56392831 |
| 108 | protein heterotetramerization (GO:0051290) | 2.56225128 |
| 109 | amino sugar catabolic process (GO:0046348) | 2.55594583 |
| 110 | mannosylation (GO:0097502) | 2.54775212 |
| 111 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.52791415 |
| 112 | * glutamate receptor signaling pathway (GO:0007215) | 2.49739794 |
| 113 | regulation of synapse assembly (GO:0051963) | 2.45599578 |
| 114 | neuronal action potential (GO:0019228) | 2.45187941 |
| 115 | short-term memory (GO:0007614) | 2.44637572 |
| 116 | regulation of respiratory system process (GO:0044065) | 2.42968098 |
| 117 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.42578484 |
| 118 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.39413539 |
| 119 | L-amino acid import (GO:0043092) | 2.38512191 |
| 120 | long-term memory (GO:0007616) | 2.37558706 |
| 121 | negative regulation of heart rate (GO:0010459) | 2.35271727 |
| 122 | mechanosensory behavior (GO:0007638) | 2.35238763 |
| 123 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.34091095 |
| 124 | * synaptic transmission, glutamatergic (GO:0035249) | 2.33534930 |
| 125 | serotonin receptor signaling pathway (GO:0007210) | 2.33495973 |
| 126 | mature B cell differentiation (GO:0002335) | 2.32208009 |
| 127 | daunorubicin metabolic process (GO:0044597) | 2.31422188 |
| 128 | polyketide metabolic process (GO:0030638) | 2.31422188 |
| 129 | doxorubicin metabolic process (GO:0044598) | 2.31422188 |
| 130 | reflex (GO:0060004) | 2.30299663 |
| 131 | melanin metabolic process (GO:0006582) | 2.29918751 |
| 132 | response to auditory stimulus (GO:0010996) | 2.29149450 |
| 133 | regulation of respiratory gaseous exchange (GO:0043576) | 2.28099683 |
| 134 | generation of neurons (GO:0048699) | 2.28025161 |
| 135 | superoxide anion generation (GO:0042554) | 2.27703484 |
| 136 | cAMP catabolic process (GO:0006198) | 2.27315857 |
| 137 | limb bud formation (GO:0060174) | 2.26919003 |
| 138 | dendritic spine morphogenesis (GO:0060997) | 2.22739336 |
| 139 | regulation of postsynaptic membrane potential (GO:0060078) | 2.22548495 |
| 140 | thyroid gland development (GO:0030878) | 2.21703850 |
| 141 | androgen biosynthetic process (GO:0006702) | 2.21287282 |
| 142 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.21273279 |
| 143 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.20822592 |
| 144 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.18253170 |
| 145 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.17911064 |
| 146 | response to folic acid (GO:0051593) | 2.17909456 |
| 147 | DNA ligation (GO:0006266) | 2.17243832 |
| 148 | cyclic nucleotide catabolic process (GO:0009214) | 2.17017809 |
| 149 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.16448759 |
| 150 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.16041867 |
| 151 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.15880614 |
| 152 | membrane assembly (GO:0071709) | 2.15666628 |
| 153 | transmission of nerve impulse (GO:0019226) | 2.15006059 |
| 154 | developmental pigmentation (GO:0048066) | 2.14571470 |
| 155 | mast cell activation (GO:0045576) | 2.13469766 |
| 156 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.13325622 |
| 157 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.13288532 |
| 158 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.11315301 |
| 159 | anatomical structure arrangement (GO:0048532) | 2.10822547 |
| 160 | oligodendrocyte differentiation (GO:0048709) | 2.10140071 |
| 161 | regulation of platelet aggregation (GO:0090330) | 2.09832804 |
| 162 | adult walking behavior (GO:0007628) | 2.08827744 |
| 163 | response to peptidoglycan (GO:0032494) | 2.08798932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * EZH2_22144423_ChIP-Seq_EOC_Human | 4.43816028 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.90493437 |
| 3 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.25613279 |
| 4 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.21692036 |
| 5 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.74413133 |
| 6 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.69432657 |
| 7 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.62545168 |
| 8 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.61186179 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.58258502 |
| 10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.54401753 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.52096592 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.52096592 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.44946817 |
| 14 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.42335629 |
| 15 | * CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.37078757 |
| 16 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.34792322 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.31081503 |
| 18 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.26509080 |
| 19 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.14347500 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.13443315 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.12093672 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.08899695 |
| 23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.08025192 |
| 24 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.04388713 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.00862508 |
| 26 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.96241174 |
| 27 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.93316691 |
| 28 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.92388703 |
| 29 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.92133419 |
| 30 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.87992589 |
| 31 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.87016638 |
| 32 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.84950987 |
| 33 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.81291504 |
| 34 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.80727031 |
| 35 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.80340508 |
| 36 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.75322531 |
| 37 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.74284076 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.69891530 |
| 39 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.68558900 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.65966790 |
| 41 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.63613817 |
| 42 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.62589996 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.60840663 |
| 44 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.59176169 |
| 45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.57866271 |
| 46 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.54817404 |
| 47 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.52320563 |
| 48 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.50587071 |
| 49 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.49643745 |
| 50 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.49148904 |
| 51 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.47611313 |
| 52 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.45414188 |
| 53 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.44231583 |
| 54 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.41700824 |
| 55 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41611854 |
| 56 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.40654039 |
| 57 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.39901419 |
| 58 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.39764374 |
| 59 | VDR_22108803_ChIP-Seq_LS180_Human | 1.39635662 |
| 60 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.38733589 |
| 61 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.37017913 |
| 62 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.36280448 |
| 63 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.34700397 |
| 64 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.32322296 |
| 65 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.31730659 |
| 66 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.30957857 |
| 67 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.29656604 |
| 68 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.28759841 |
| 69 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.25289819 |
| 70 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.25018625 |
| 71 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.24740736 |
| 72 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.24167810 |
| 73 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.23786342 |
| 74 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22705619 |
| 75 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.22492864 |
| 76 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.21549317 |
| 77 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21091507 |
| 78 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.20061919 |
| 79 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.20038550 |
| 80 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.19342122 |
| 81 | * AR_19668381_ChIP-Seq_PC3_Human | 1.17962502 |
| 82 | TP53_16413492_ChIP-PET_HCT116_Human | 1.16118643 |
| 83 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.15612260 |
| 84 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.15027497 |
| 85 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.14570824 |
| 86 | FUS_26573619_Chip-Seq_HEK293_Human | 1.14466153 |
| 87 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.14219680 |
| 88 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.14061476 |
| 89 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.13730073 |
| 90 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.13654620 |
| 91 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.13340762 |
| 92 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.12981942 |
| 93 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.12885252 |
| 94 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12605208 |
| 95 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.11475948 |
| 96 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.11275564 |
| 97 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.09751934 |
| 98 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.07383233 |
| 99 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.07120490 |
| 100 | TCF4_23295773_ChIP-Seq_U87_Human | 1.06426463 |
| 101 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.06393979 |
| 102 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.06378570 |
| 103 | KDM2B_26808549_Chip-Seq_REH_Human | 1.06189451 |
| 104 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05813740 |
| 105 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.04904510 |
| 106 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.03864546 |
| 107 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03784678 |
| 108 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02918996 |
| 109 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.02908978 |
| 110 | STAT3_23295773_ChIP-Seq_U87_Human | 1.02576561 |
| 111 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01875053 |
| 112 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.01812320 |
| 113 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.01642076 |
| 114 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.01236132 |
| 115 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.00870576 |
| 116 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.00357131 |
| 117 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.99877031 |
| 118 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.99557095 |
| 119 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99470235 |
| 120 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.99138057 |
| 121 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98307388 |
| 122 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.98236665 |
| 123 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98236665 |
| 124 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.98041359 |
| 125 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97659032 |
| 126 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.97211461 |
| 127 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97083890 |
| 128 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.96349655 |
| 129 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95472472 |
| 130 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.94693550 |
| 131 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.94044597 |
| 132 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.91705134 |
| 133 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91268586 |
| 134 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.89957056 |
| 135 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87100906 |
| 136 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86094125 |
| 137 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85173812 |
| 138 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.83593444 |
| 139 | JUN_21703547_ChIP-Seq_K562_Human | 0.82676294 |
| 140 | KDM2B_26808549_Chip-Seq_K562_Human | 0.82174362 |
| 141 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.81800145 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 4.32954415 |
| 2 | MP0003880_abnormal_central_pattern | 4.01980626 |
| 3 | MP0001188_hyperpigmentation | 3.53470406 |
| 4 | MP0005409_darkened_coat_color | 3.32981373 |
| 5 | MP0006292_abnormal_olfactory_placode | 3.28952831 |
| 6 | MP0009379_abnormal_foot_pigmentation | 2.88995798 |
| 7 | MP0004859_abnormal_synaptic_plasticity | 2.75195710 |
| 8 | MP0001968_abnormal_touch/_nociception | 2.70988644 |
| 9 | MP0001986_abnormal_taste_sensitivity | 2.66164139 |
| 10 | MP0004381_abnormal_hair_follicle | 2.42387869 |
| 11 | MP0002735_abnormal_chemical_nociception | 2.39609823 |
| 12 | MP0003183_abnormal_peptide_metabolism | 2.26640109 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.21644849 |
| 14 | MP0005174_abnormal_tail_pigmentation | 2.20824602 |
| 15 | MP0004885_abnormal_endolymph | 2.12678443 |
| 16 | MP0001486_abnormal_startle_reflex | 2.12429970 |
| 17 | MP0002736_abnormal_nociception_after | 2.09187501 |
| 18 | MP0009745_abnormal_behavioral_response | 2.05038489 |
| 19 | MP0002638_abnormal_pupillary_reflex | 2.02353873 |
| 20 | MP0006276_abnormal_autonomic_nervous | 1.97635303 |
| 21 | MP0002653_abnormal_ependyma_morphology | 1.96839446 |
| 22 | MP0000015_abnormal_ear_pigmentation | 1.95274241 |
| 23 | MP0002876_abnormal_thyroid_physiology | 1.94210225 |
| 24 | * MP0003635_abnormal_synaptic_transmissio | 1.92314270 |
| 25 | MP0000372_irregular_coat_pigmentation | 1.88867195 |
| 26 | MP0002822_catalepsy | 1.88167129 |
| 27 | MP0000566_synostosis | 1.86757161 |
| 28 | MP0002102_abnormal_ear_morphology | 1.78684798 |
| 29 | MP0005171_absent_coat_pigmentation | 1.76929630 |
| 30 | MP0002734_abnormal_mechanical_nocicepti | 1.72227027 |
| 31 | * MP0002272_abnormal_nervous_system | 1.71679555 |
| 32 | MP0004270_analgesia | 1.68862849 |
| 33 | MP0009046_muscle_twitch | 1.62581288 |
| 34 | MP0008260_abnormal_autophagy | 1.60171557 |
| 35 | MP0002572_abnormal_emotion/affect_behav | 1.58852381 |
| 36 | MP0001984_abnormal_olfaction | 1.57934677 |
| 37 | * MP0002064_seizures | 1.54586627 |
| 38 | * MP0002067_abnormal_sensory_capabilities | 1.53524819 |
| 39 | MP0001970_abnormal_pain_threshold | 1.53104056 |
| 40 | MP0003283_abnormal_digestive_organ | 1.52507774 |
| 41 | MP0004742_abnormal_vestibular_system | 1.51405561 |
| 42 | MP0003787_abnormal_imprinting | 1.50198903 |
| 43 | MP0005646_abnormal_pituitary_gland | 1.49080677 |
| 44 | MP0003690_abnormal_glial_cell | 1.47071377 |
| 45 | MP0003724_increased_susceptibility_to | 1.46791544 |
| 46 | MP0002063_abnormal_learning/memory/cond | 1.44842923 |
| 47 | MP0005645_abnormal_hypothalamus_physiol | 1.43120837 |
| 48 | MP0002184_abnormal_innervation | 1.41350942 |
| 49 | MP0003329_amyloid_beta_deposits | 1.41176617 |
| 50 | MP0002277_abnormal_respiratory_mucosa | 1.40990334 |
| 51 | MP0004142_abnormal_muscle_tone | 1.40387532 |
| 52 | MP0002557_abnormal_social/conspecific_i | 1.39116058 |
| 53 | MP0009780_abnormal_chondrocyte_physiolo | 1.37299301 |
| 54 | MP0002733_abnormal_thermal_nociception | 1.36976940 |
| 55 | MP0005075_abnormal_melanosome_morpholog | 1.33030736 |
| 56 | MP0003879_abnormal_hair_cell | 1.32904298 |
| 57 | MP0008569_lethality_at_weaning | 1.26504984 |
| 58 | MP0001905_abnormal_dopamine_level | 1.26448198 |
| 59 | MP0002152_abnormal_brain_morphology | 1.26331471 |
| 60 | MP0000778_abnormal_nervous_system | 1.25769505 |
| 61 | MP0000681_abnormal_thyroid_gland | 1.25729810 |
| 62 | MP0002148_abnormal_hypersensitivity_rea | 1.25008944 |
| 63 | MP0005499_abnormal_olfactory_system | 1.23146847 |
| 64 | MP0005394_taste/olfaction_phenotype | 1.23146847 |
| 65 | MP0002095_abnormal_skin_pigmentation | 1.23068676 |
| 66 | MP0003938_abnormal_ear_development | 1.21682091 |
| 67 | MP0001963_abnormal_hearing_physiology | 1.21225822 |
| 68 | MP0000026_abnormal_inner_ear | 1.21105572 |
| 69 | MP0003122_maternal_imprinting | 1.19718854 |
| 70 | MP0008877_abnormal_DNA_methylation | 1.19215866 |
| 71 | MP0001501_abnormal_sleep_pattern | 1.14870065 |
| 72 | MP0003631_nervous_system_phenotype | 1.14048637 |
| 73 | MP0002751_abnormal_autonomic_nervous | 1.14022252 |
| 74 | MP0003634_abnormal_glial_cell | 1.11977433 |
| 75 | MP0002249_abnormal_larynx_morphology | 1.11574493 |
| 76 | MP0003119_abnormal_digestive_system | 1.11450292 |
| 77 | MP0003632_abnormal_nervous_system | 1.10472411 |
| 78 | MP0000631_abnormal_neuroendocrine_gland | 1.07943054 |
| 79 | MP0002177_abnormal_outer_ear | 1.05464874 |
| 80 | MP0001440_abnormal_grooming_behavior | 1.03607955 |
| 81 | MP0010386_abnormal_urinary_bladder | 1.03456001 |
| 82 | MP0000049_abnormal_middle_ear | 1.02972162 |
| 83 | MP0008789_abnormal_olfactory_epithelium | 1.02608474 |
| 84 | MP0002009_preneoplasia | 1.00962492 |
| 85 | MP0003315_abnormal_perineum_morphology | 0.99406727 |
| 86 | MP0001502_abnormal_circadian_rhythm | 0.96213740 |
| 87 | MP0001485_abnormal_pinna_reflex | 0.96160577 |
| 88 | MP0002752_abnormal_somatic_nervous | 0.95086732 |
| 89 | MP0005187_abnormal_penis_morphology | 0.94771877 |
| 90 | MP0003890_abnormal_embryonic-extraembry | 0.94408949 |
| 91 | MP0003121_genomic_imprinting | 0.94070853 |
| 92 | MP0009785_altered_susceptibility_to | 0.93619799 |
| 93 | MP0006072_abnormal_retinal_apoptosis | 0.93140490 |
| 94 | MP0002938_white_spotting | 0.92398751 |
| 95 | MP0001177_atelectasis | 0.92262398 |
| 96 | MP0003861_abnormal_nervous_system | 0.91877227 |
| 97 | MP0001664_abnormal_digestion | 0.90675075 |
| 98 | MP0001835_abnormal_antigen_presentation | 0.89860173 |
| 99 | MP0001346_abnormal_lacrimal_gland | 0.89064672 |
| 100 | MP0005671_abnormal_response_to | 0.88749357 |
| 101 | * MP0002882_abnormal_neuron_morphology | 0.86287034 |
| 102 | MP0005551_abnormal_eye_electrophysiolog | 0.84447801 |
| 103 | MP0005253_abnormal_eye_physiology | 0.81586305 |
| 104 | MP0005167_abnormal_blood-brain_barrier | 0.80517282 |
| 105 | MP0002234_abnormal_pharynx_morphology | 0.80400505 |
| 106 | MP0000920_abnormal_myelination | 0.76287112 |
| 107 | MP0000955_abnormal_spinal_cord | 0.75424592 |
| 108 | MP0005379_endocrine/exocrine_gland_phen | 0.75073030 |
| 109 | MP0002928_abnormal_bile_duct | 0.72946743 |
| 110 | MP0008995_early_reproductive_senescence | 0.72762399 |
| 111 | MP0002163_abnormal_gland_morphology | 0.72756259 |
| 112 | MP0004043_abnormal_pH_regulation | 0.71607786 |
| 113 | MP0000534_abnormal_ureter_morphology | 0.71283737 |
| 114 | MP0005000_abnormal_immune_tolerance | 0.70594054 |
| 115 | MP0001348_abnormal_lacrimal_gland | 0.68018601 |
| 116 | MP0002069_abnormal_eating/drinking_beha | 0.67652007 |
| 117 | MP0001529_abnormal_vocalization | 0.66545925 |
| 118 | MP0005084_abnormal_gallbladder_morpholo | 0.65216991 |
| 119 | MP0004133_heterotaxia | 0.65088340 |
| 120 | * MP0002066_abnormal_motor_capabilities/c | 0.64925172 |
| 121 | MP0004924_abnormal_behavior | 0.64188687 |
| 122 | MP0005386_behavior/neurological_phenoty | 0.64188687 |
| 123 | MP0004145_abnormal_muscle_electrophysio | 0.63781222 |
| 124 | MP0002229_neurodegeneration | 0.62012276 |
| 125 | MP0001919_abnormal_reproductive_system | 0.61207281 |
| 126 | MP0002419_abnormal_innate_immunity | 0.60531413 |
| 127 | MP0004510_myositis | 0.60086592 |
| 128 | MP0003137_abnormal_impulse_conducting | 0.59929989 |
| 129 | MP0000579_abnormal_nail_morphology | 0.58886477 |
| 130 | MP0005025_abnormal_response_to | 0.58109865 |
| 131 | MP0009250_abnormal_appendicular_skeleto | 0.57748563 |
| 132 | MP0004811_abnormal_neuron_physiology | 0.57025693 |
| 133 | MP0004147_increased_porphyrin_level | 0.56760749 |
| 134 | MP0005195_abnormal_posterior_eye | 0.56666407 |
| 135 | MP0002909_abnormal_adrenal_gland | 0.56622904 |
| 136 | MP0002160_abnormal_reproductive_system | 0.56537634 |
| 137 | MP0003941_abnormal_skin_development | 0.54366809 |
| 138 | MP0003633_abnormal_nervous_system | 0.53534566 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 4.97206097 |
| 2 | Atonic seizures (HP:0010819) | 4.72532421 |
| 3 | Type I transferrin isoform profile (HP:0003642) | 3.89647725 |
| 4 | Nonprogressive disorder (HP:0003680) | 3.80548449 |
| 5 | Abnormality of the axillary hair (HP:0100134) | 3.49752342 |
| 6 | Abnormality of secondary sexual hair (HP:0009888) | 3.49752342 |
| 7 | Absence seizures (HP:0002121) | 3.46550851 |
| 8 | Febrile seizures (HP:0002373) | 3.45543043 |
| 9 | Neurofibrillary tangles (HP:0002185) | 3.33453157 |
| 10 | Reduced antithrombin III activity (HP:0001976) | 3.27473171 |
| 11 | Oligodactyly (hands) (HP:0001180) | 3.27073171 |
| 12 | Dialeptic seizures (HP:0011146) | 3.20809710 |
| 13 | Hypothermia (HP:0002045) | 3.19811374 |
| 14 | Myokymia (HP:0002411) | 3.17175286 |
| 15 | Hemiparesis (HP:0001269) | 3.08942654 |
| 16 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.06759170 |
| 17 | Absent/shortened dynein arms (HP:0200106) | 3.06759170 |
| 18 | Supranuclear gaze palsy (HP:0000605) | 3.05512451 |
| 19 | Abnormality of binocular vision (HP:0011514) | 3.03443346 |
| 20 | Diplopia (HP:0000651) | 3.03443346 |
| 21 | Hemiplegia (HP:0002301) | 2.94607071 |
| 22 | Thyroid-stimulating hormone excess (HP:0002925) | 2.90574848 |
| 23 | Generalized tonic-clonic seizures (HP:0002069) | 2.89166375 |
| 24 | Dysdiadochokinesis (HP:0002075) | 2.80267836 |
| 25 | Abnormal ciliary motility (HP:0012262) | 2.80220552 |
| 26 | 3-Methylglutaconic aciduria (HP:0003535) | 2.77386726 |
| 27 | Parakeratosis (HP:0001036) | 2.74226476 |
| 28 | Oligodactyly (HP:0012165) | 2.72770607 |
| 29 | True hermaphroditism (HP:0010459) | 2.71914732 |
| 30 | Patchy hypopigmentation of hair (HP:0011365) | 2.68229654 |
| 31 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.65974012 |
| 32 | Gait imbalance (HP:0002141) | 2.58453818 |
| 33 | Abnormality of the diencephalon (HP:0010662) | 2.58126966 |
| 34 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.56201910 |
| 35 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.56201910 |
| 36 | Abnormal sex determination (HP:0012244) | 2.54903999 |
| 37 | Sex reversal (HP:0012245) | 2.54903999 |
| 38 | Hyperventilation (HP:0002883) | 2.54112803 |
| 39 | Truncal ataxia (HP:0002078) | 2.52424873 |
| 40 | Abnormal eating behavior (HP:0100738) | 2.50589575 |
| 41 | Gaze-evoked nystagmus (HP:0000640) | 2.49000256 |
| 42 | Torticollis (HP:0000473) | 2.48357746 |
| 43 | White forelock (HP:0002211) | 2.47898028 |
| 44 | Megalencephaly (HP:0001355) | 2.47531336 |
| 45 | Progressive cerebellar ataxia (HP:0002073) | 2.47122680 |
| 46 | Bundle branch block (HP:0011710) | 2.47074200 |
| 47 | Dry hair (HP:0011359) | 2.46885677 |
| 48 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.46576170 |
| 49 | Vitreoretinal degeneration (HP:0000655) | 2.43879253 |
| 50 | Bronchomalacia (HP:0002780) | 2.41221808 |
| 51 | Postural instability (HP:0002172) | 2.38965984 |
| 52 | Peripheral hypomyelination (HP:0007182) | 2.38444650 |
| 53 | Type II lissencephaly (HP:0007260) | 2.33847382 |
| 54 | Abnormal protein glycosylation (HP:0012346) | 2.32261600 |
| 55 | Abnormal glycosylation (HP:0012345) | 2.32261600 |
| 56 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.32261600 |
| 57 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.32261600 |
| 58 | Spastic gait (HP:0002064) | 2.31451727 |
| 59 | Anterior segment dysgenesis (HP:0007700) | 2.30845068 |
| 60 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.30687984 |
| 61 | Abnormality of magnesium homeostasis (HP:0004921) | 2.30542718 |
| 62 | Morphological abnormality of the inner ear (HP:0011390) | 2.29728391 |
| 63 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.29487231 |
| 64 | Optic nerve hypoplasia (HP:0000609) | 2.28135011 |
| 65 | Rib fusion (HP:0000902) | 2.27202990 |
| 66 | Polyphagia (HP:0002591) | 2.25248075 |
| 67 | Maternal diabetes (HP:0009800) | 2.23766722 |
| 68 | Attenuation of retinal blood vessels (HP:0007843) | 2.22622463 |
| 69 | Genital tract atresia (HP:0001827) | 2.21217904 |
| 70 | Absent septum pellucidum (HP:0001331) | 2.21007850 |
| 71 | Cerebral inclusion bodies (HP:0100314) | 2.20678078 |
| 72 | Intention tremor (HP:0002080) | 2.20621612 |
| 73 | Vaginal atresia (HP:0000148) | 2.19503724 |
| 74 | Abnormality of the labia minora (HP:0012880) | 2.19054329 |
| 75 | Decreased central vision (HP:0007663) | 2.18392454 |
| 76 | Ulnar claw (HP:0001178) | 2.17671385 |
| 77 | Short tibia (HP:0005736) | 2.17347968 |
| 78 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.16951434 |
| 79 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.16864531 |
| 80 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.16252088 |
| 81 | Septo-optic dysplasia (HP:0100842) | 2.16190070 |
| 82 | Severe visual impairment (HP:0001141) | 2.16181985 |
| 83 | Ankle clonus (HP:0011448) | 2.15918209 |
| 84 | Renal Fanconi syndrome (HP:0001994) | 2.15572619 |
| 85 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.12177691 |
| 86 | Retinal dysplasia (HP:0007973) | 2.12014292 |
| 87 | Retrobulbar optic neuritis (HP:0100654) | 2.11828005 |
| 88 | Optic neuritis (HP:0100653) | 2.11828005 |
| 89 | Sleep apnea (HP:0010535) | 2.11729500 |
| 90 | Supernumerary spleens (HP:0009799) | 2.09976986 |
| 91 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.08951074 |
| 92 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.08951074 |
| 93 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.08887886 |
| 94 | Esophageal atresia (HP:0002032) | 2.08824532 |
| 95 | Esotropia (HP:0000565) | 2.07303427 |
| 96 | Anophthalmia (HP:0000528) | 2.07280646 |
| 97 | Chronic obstructive pulmonary disease (HP:0006510) | 2.06167412 |
| 98 | Obstructive lung disease (HP:0006536) | 2.06167412 |
| 99 | Status epilepticus (HP:0002133) | 2.05487748 |
| 100 | Stomatitis (HP:0010280) | 2.04584412 |
| 101 | Focal dystonia (HP:0004373) | 2.04271136 |
| 102 | Focal seizures (HP:0007359) | 2.04200825 |
| 103 | Type 2 muscle fiber atrophy (HP:0003554) | 2.03495920 |
| 104 | Increased circulating renin level (HP:0000848) | 2.03447218 |
| 105 | Conical tooth (HP:0000698) | 2.00221748 |
| 106 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.00108012 |
| 107 | Congenital primary aphakia (HP:0007707) | 1.99737960 |
| 108 | Abnormality of the septum pellucidum (HP:0007375) | 1.98977679 |
| 109 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.98676852 |
| 110 | Aplasia of the phalanges of the hand (HP:0009802) | 1.98676852 |
| 111 | Aplasia involving bones of the extremities (HP:0009825) | 1.98676852 |
| 112 | Hypomagnesemia (HP:0002917) | 1.98316920 |
| 113 | Broad-based gait (HP:0002136) | 1.98131073 |
| 114 | Epileptiform EEG discharges (HP:0011182) | 1.97481201 |
| 115 | Optic disc pallor (HP:0000543) | 1.96027144 |
| 116 | Dysmetria (HP:0001310) | 1.95672938 |
| 117 | Protruding tongue (HP:0010808) | 1.94793483 |
| 118 | Specific learning disability (HP:0001328) | 1.94353639 |
| 119 | Hypoplasia of the fovea (HP:0007750) | 1.94205162 |
| 120 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.94205162 |
| 121 | Epileptic encephalopathy (HP:0200134) | 1.94099280 |
| 122 | Abnormality of the corticospinal tract (HP:0002492) | 1.93671949 |
| 123 | Pheochromocytoma (HP:0002666) | 1.91596328 |
| 124 | Impaired smooth pursuit (HP:0007772) | 1.91116062 |
| 125 | Pancreatic fibrosis (HP:0100732) | 1.90618234 |
| 126 | Split foot (HP:0001839) | 1.88555011 |
| 127 | Bradycardia (HP:0001662) | 1.88396140 |
| 128 | Humeroradial synostosis (HP:0003041) | 1.87896488 |
| 129 | Synostosis involving the elbow (HP:0003938) | 1.87896488 |
| 130 | Increased hepatocellular lipid droplets (HP:0006565) | 1.87393461 |
| 131 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.87306520 |
| 132 | Amblyopia (HP:0000646) | 1.86785586 |
| 133 | Lissencephaly (HP:0001339) | 1.85743154 |
| 134 | Meningitis (HP:0001287) | 1.85122792 |
| 135 | Median cleft lip (HP:0000161) | 1.84344130 |
| 136 | Turricephaly (HP:0000262) | 1.83276813 |
| 137 | Amelogenesis imperfecta (HP:0000705) | 1.82945157 |
| 138 | Abnormality of cochlea (HP:0000375) | 1.80672058 |
| 139 | Keratoconus (HP:0000563) | 1.80063183 |
| 140 | Increased corneal curvature (HP:0100692) | 1.80063183 |
| 141 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.79955456 |
| 142 | Agitation (HP:0000713) | 1.79441183 |
| 143 | Mediastinal lymphadenopathy (HP:0100721) | 1.78150090 |
| 144 | Scanning speech (HP:0002168) | 1.77948144 |
| 145 | Large eyes (HP:0001090) | 1.76781885 |
| 146 | Abnormality of midbrain morphology (HP:0002418) | 1.76521834 |
| 147 | Molar tooth sign on MRI (HP:0002419) | 1.76521834 |
| 148 | Medial flaring of the eyebrow (HP:0010747) | 1.74285218 |
| 149 | Action tremor (HP:0002345) | 1.74153220 |
| 150 | Abnormality of renal resorption (HP:0011038) | 1.73655347 |
| 151 | Abnormality of dental color (HP:0011073) | 1.73627073 |
| 152 | Nephrogenic diabetes insipidus (HP:0009806) | 1.73163100 |
| 153 | Anencephaly (HP:0002323) | 1.72970435 |
| 154 | Abnormality of incisor morphology (HP:0011063) | 1.72737629 |
| 155 | EEG with generalized epileptiform discharges (HP:0011198) | 1.72359558 |
| 156 | Ventricular fibrillation (HP:0001663) | 1.72089897 |
| 157 | Male pseudohermaphroditism (HP:0000037) | 1.69452725 |
| 158 | Craniofacial dystonia (HP:0012179) | 1.68164192 |
| 159 | Preaxial hand polydactyly (HP:0001177) | 1.67325502 |
| 160 | Poor coordination (HP:0002370) | 1.67171646 |
| 161 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.66685456 |
| 162 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.66638219 |
| 163 | Progressive inability to walk (HP:0002505) | 1.66610383 |
| 164 | Neuroendocrine neoplasm (HP:0100634) | 1.66352549 |
| 165 | Limb dystonia (HP:0002451) | 1.66339596 |
| 166 | Anomalous pulmonary venous return (HP:0010772) | 1.65823404 |
| 167 | Hypoplasia of the brainstem (HP:0002365) | 1.65735061 |
| 168 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.65735061 |
| 169 | Anxiety (HP:0000739) | 1.65684771 |
| 170 | Abnormality of the fovea (HP:0000493) | 1.65416383 |
| 171 | Muscle fiber atrophy (HP:0100295) | 1.64944888 |
| 172 | Heart block (HP:0012722) | 1.63565101 |
| 173 | Chromsome breakage (HP:0040012) | 1.63499946 |
| 174 | Congenital sensorineural hearing impairment (HP:0008527) | 1.63091340 |
| 175 | Inability to walk (HP:0002540) | 1.63077581 |
| 176 | Clubbing of toes (HP:0100760) | 1.62946137 |
| 177 | Agammaglobulinemia (HP:0004432) | 1.62850470 |
| 178 | Nephronophthisis (HP:0000090) | 1.62611686 |
| 179 | Fair hair (HP:0002286) | 1.62068504 |
| 180 | Obstructive sleep apnea (HP:0002870) | 1.61816851 |
| 181 | Pancreatic cysts (HP:0001737) | 1.61385321 |
| 182 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.61265312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.80121851 |
| 2 | TNIK | 4.74349643 |
| 3 | MUSK | 4.05755384 |
| 4 | PNCK | 3.62730413 |
| 5 | MKNK2 | 3.22032772 |
| 6 | PRKD3 | 2.63143286 |
| 7 | TYRO3 | 2.55955588 |
| 8 | MAPK15 | 2.55929740 |
| 9 | MAP2K7 | 2.50994811 |
| 10 | PAK6 | 2.30155739 |
| 11 | NTRK3 | 2.23587022 |
| 12 | MAP3K12 | 2.16095480 |
| 13 | WNK3 | 2.15405179 |
| 14 | MAPK13 | 2.09052184 |
| 15 | STK16 | 2.04102383 |
| 16 | MKNK1 | 1.93743379 |
| 17 | PRPF4B | 1.92738548 |
| 18 | MAP3K9 | 1.84452632 |
| 19 | FES | 1.78601203 |
| 20 | NME2 | 1.78425733 |
| 21 | TXK | 1.77676306 |
| 22 | RIPK4 | 1.67675619 |
| 23 | NLK | 1.66655674 |
| 24 | ADRBK2 | 1.62606935 |
| 25 | CAMKK1 | 1.57835854 |
| 26 | IRAK4 | 1.54671763 |
| 27 | CDK19 | 1.52390157 |
| 28 | EPHA4 | 1.47564382 |
| 29 | NTRK1 | 1.46217538 |
| 30 | IRAK3 | 1.42843944 |
| 31 | MAP2K4 | 1.39438815 |
| 32 | YES1 | 1.38245855 |
| 33 | EIF2AK3 | 1.29583084 |
| 34 | TEC | 1.28135963 |
| 35 | BMPR2 | 1.27521815 |
| 36 | TAOK3 | 1.23771344 |
| 37 | TLK1 | 1.23285249 |
| 38 | GRK7 | 1.21071806 |
| 39 | BMPR1B | 1.20033621 |
| 40 | PLK4 | 1.20013136 |
| 41 | EIF2AK2 | 1.18939918 |
| 42 | CSNK1G2 | 1.16325257 |
| 43 | IRAK2 | 1.16122436 |
| 44 | CAMK1 | 1.14708202 |
| 45 | LATS2 | 1.10681934 |
| 46 | NEK6 | 1.05963189 |
| 47 | GRK5 | 1.05432595 |
| 48 | TSSK6 | 1.05063361 |
| 49 | PRKD2 | 1.04625887 |
| 50 | SRPK1 | 1.04583122 |
| 51 | PINK1 | 1.03761360 |
| 52 | MAP3K14 | 1.03340715 |
| 53 | TNK2 | 1.02981674 |
| 54 | CDK3 | 1.01234722 |
| 55 | CLK1 | 0.98178280 |
| 56 | NTRK2 | 0.97577199 |
| 57 | EPHB2 | 0.97553283 |
| 58 | GRK1 | 0.96033076 |
| 59 | SIK3 | 0.95724209 |
| 60 | IRAK1 | 0.91885868 |
| 61 | MAPKAPK5 | 0.89881941 |
| 62 | ARAF | 0.89054618 |
| 63 | CAMKK2 | 0.88945827 |
| 64 | PHKG2 | 0.88893232 |
| 65 | PHKG1 | 0.88893232 |
| 66 | KSR1 | 0.87953215 |
| 67 | CAMK1D | 0.85880769 |
| 68 | MARK1 | 0.84877842 |
| 69 | TIE1 | 0.83667472 |
| 70 | BLK | 0.82633705 |
| 71 | FGFR2 | 0.81553908 |
| 72 | PRKCZ | 0.79742633 |
| 73 | PLK2 | 0.77895759 |
| 74 | KIT | 0.77140795 |
| 75 | SGK2 | 0.74821566 |
| 76 | CSNK1D | 0.74741418 |
| 77 | EPHA3 | 0.74467065 |
| 78 | CAMK2B | 0.72241955 |
| 79 | CAMK2A | 0.70323697 |
| 80 | PRKCH | 0.70135194 |
| 81 | CSNK1G1 | 0.68399870 |
| 82 | DYRK1A | 0.67456431 |
| 83 | WEE1 | 0.67092652 |
| 84 | MAPK10 | 0.66815435 |
| 85 | SGK494 | 0.66256195 |
| 86 | SGK223 | 0.66256195 |
| 87 | CAMK1G | 0.65855624 |
| 88 | WNK4 | 0.65172172 |
| 89 | MAPK7 | 0.64716562 |
| 90 | RET | 0.64316379 |
| 91 | PRKG2 | 0.63718904 |
| 92 | UHMK1 | 0.63557348 |
| 93 | WNK1 | 0.59944915 |
| 94 | OXSR1 | 0.59734732 |
| 95 | MAPK12 | 0.59229825 |
| 96 | PRKCE | 0.59191840 |
| 97 | STK11 | 0.58228628 |
| 98 | PKN1 | 0.57972676 |
| 99 | VRK1 | 0.57665895 |
| 100 | SYK | 0.57651747 |
| 101 | IKBKB | 0.57645934 |
| 102 | ROCK2 | 0.56038223 |
| 103 | MATK | 0.55329392 |
| 104 | SGK1 | 0.55310320 |
| 105 | LYN | 0.54681519 |
| 106 | BTK | 0.53423562 |
| 107 | CDK8 | 0.52543386 |
| 108 | CDK5 | 0.51844259 |
| 109 | CSNK1A1L | 0.50959958 |
| 110 | MAP2K6 | 0.50628117 |
| 111 | INSRR | 0.50205692 |
| 112 | MINK1 | 0.49996231 |
| 113 | DYRK2 | 0.49957484 |
| 114 | SIK2 | 0.49924003 |
| 115 | CDK15 | 0.49883888 |
| 116 | PRKCG | 0.49439314 |
| 117 | IKBKE | 0.48155382 |
| 118 | CDK18 | 0.47730646 |
| 119 | STK38L | 0.46786948 |
| 120 | RPS6KA3 | 0.45367331 |
| 121 | CDK14 | 0.44604407 |
| 122 | MAP3K13 | 0.44367534 |
| 123 | CAMK2D | 0.43616974 |
| 124 | CDK11A | 0.43590076 |
| 125 | NME1 | 0.42549961 |
| 126 | PRKG1 | 0.42500077 |
| 127 | PIM2 | 0.42260268 |
| 128 | MAPK4 | 0.41195871 |
| 129 | ZAK | 0.40532077 |
| 130 | STK38 | 0.40475409 |
| 131 | PRKACA | 0.40384267 |
| 132 | MARK2 | 0.40127566 |
| 133 | LRRK2 | 0.39787687 |
| 134 | KSR2 | 0.39390833 |
| 135 | ROCK1 | 0.38483622 |
| 136 | HIPK2 | 0.36689365 |
| 137 | HCK | 0.36683647 |
| 138 | CAMK2G | 0.34595760 |
| 139 | TAOK2 | 0.34564501 |
| 140 | STK39 | 0.33592646 |
| 141 | MAP3K1 | 0.32522100 |
| 142 | CSNK1G3 | 0.32144730 |
| 143 | MAP3K4 | 0.32114321 |
| 144 | PDGFRB | 0.31658911 |
| 145 | DAPK2 | 0.30344887 |
| 146 | LIMK1 | 0.29995946 |
| 147 | PRKDC | 0.29626627 |
| 148 | ERBB2 | 0.29454667 |
| 149 | AKT2 | 0.29060282 |
| 150 | ADRBK1 | 0.28007690 |
| 151 | CAMK4 | 0.25740172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.13976757 |
| 2 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.76766078 |
| 3 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.32534521 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.27536635 |
| 5 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.04910323 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 1.97103251 |
| 7 | Taste transduction_Homo sapiens_hsa04742 | 1.94270418 |
| 8 | Phototransduction_Homo sapiens_hsa04744 | 1.85284813 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.84123412 |
| 10 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 1.81021663 |
| 11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.77418335 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.77409188 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.68635094 |
| 14 | Circadian entrainment_Homo sapiens_hsa04713 | 1.67118812 |
| 15 | Ribosome_Homo sapiens_hsa03010 | 1.66096362 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.65976061 |
| 17 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.55481714 |
| 18 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.54340767 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.53979944 |
| 20 | GABAergic synapse_Homo sapiens_hsa04727 | 1.53584851 |
| 21 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.50215506 |
| 22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.48072212 |
| 23 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.48040737 |
| 24 | Salivary secretion_Homo sapiens_hsa04970 | 1.47122056 |
| 25 | Allograft rejection_Homo sapiens_hsa05330 | 1.45990258 |
| 26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.41208111 |
| 27 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.40974114 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.40874248 |
| 29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.38181196 |
| 30 | Long-term depression_Homo sapiens_hsa04730 | 1.36571755 |
| 31 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.33086337 |
| 32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.28835147 |
| 33 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.24954777 |
| 34 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.22761131 |
| 35 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.22685902 |
| 36 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.20578870 |
| 37 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.19115715 |
| 38 | Asthma_Homo sapiens_hsa05310 | 1.18059812 |
| 39 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.17218765 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.13684590 |
| 41 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.09509077 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.09011227 |
| 43 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.08147911 |
| 44 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.07897846 |
| 45 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.07359954 |
| 46 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.07290752 |
| 47 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.04089497 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.01502618 |
| 49 | Protein export_Homo sapiens_hsa03060 | 1.01027025 |
| 50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.00529137 |
| 51 | Insulin secretion_Homo sapiens_hsa04911 | 1.00526321 |
| 52 | Bile secretion_Homo sapiens_hsa04976 | 0.97528224 |
| 53 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.97350216 |
| 54 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.97271276 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 0.97146322 |
| 56 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.95783092 |
| 57 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.95279514 |
| 58 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.94918436 |
| 59 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.93393592 |
| 60 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.92759212 |
| 61 | Long-term potentiation_Homo sapiens_hsa04720 | 0.92140646 |
| 62 | Axon guidance_Homo sapiens_hsa04360 | 0.91601087 |
| 63 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.87286443 |
| 64 | Alzheimers disease_Homo sapiens_hsa05010 | 0.86921073 |
| 65 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.83740296 |
| 66 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.83560897 |
| 67 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.83054950 |
| 68 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.82755000 |
| 69 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.82313316 |
| 70 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.79984157 |
| 71 | Renin secretion_Homo sapiens_hsa04924 | 0.79841417 |
| 72 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.79182155 |
| 73 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.76420093 |
| 74 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76197615 |
| 75 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.75492109 |
| 76 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.75439028 |
| 77 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.74846298 |
| 78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74375893 |
| 79 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.74097181 |
| 80 | Parkinsons disease_Homo sapiens_hsa05012 | 0.73956484 |
| 81 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.73670131 |
| 82 | Melanogenesis_Homo sapiens_hsa04916 | 0.73009319 |
| 83 | Cocaine addiction_Homo sapiens_hsa05030 | 0.72312357 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71062294 |
| 85 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.70944779 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70387584 |
| 87 | Malaria_Homo sapiens_hsa05144 | 0.70008502 |
| 88 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.69840240 |
| 89 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.68711547 |
| 90 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.68504596 |
| 91 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.67895142 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67167142 |
| 93 | Homologous recombination_Homo sapiens_hsa03440 | 0.65228449 |
| 94 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.64840932 |
| 95 | Glioma_Homo sapiens_hsa05214 | 0.64733429 |
| 96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.63818877 |
| 97 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63675702 |
| 98 | Leishmaniasis_Homo sapiens_hsa05140 | 0.62822742 |
| 99 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.61475463 |
| 100 | Prion diseases_Homo sapiens_hsa05020 | 0.61448204 |
| 101 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.60511003 |
| 102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60438240 |
| 103 | Basal transcription factors_Homo sapiens_hsa03022 | 0.60331709 |
| 104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59621438 |
| 105 | Purine metabolism_Homo sapiens_hsa00230 | 0.59429293 |
| 106 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59263932 |
| 107 | Huntingtons disease_Homo sapiens_hsa05016 | 0.58772331 |
| 108 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58305099 |
| 109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58230154 |
| 110 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56255459 |
| 111 | Measles_Homo sapiens_hsa05162 | 0.55618578 |
| 112 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55523710 |
| 113 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55512670 |
| 114 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55277767 |
| 115 | Tight junction_Homo sapiens_hsa04530 | 0.54901807 |
| 116 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.52868271 |
| 117 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51914784 |
| 118 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.51314306 |
| 119 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50647956 |
| 120 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.48822973 |
| 121 | Salmonella infection_Homo sapiens_hsa05132 | 0.48589608 |
| 122 | Pertussis_Homo sapiens_hsa05133 | 0.48219489 |
| 123 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48061080 |
| 124 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47006911 |
| 125 | Gap junction_Homo sapiens_hsa04540 | 0.46550912 |
| 126 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46434930 |
| 127 | ABC transporters_Homo sapiens_hsa02010 | 0.46253040 |
| 128 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45954870 |
| 129 | Tuberculosis_Homo sapiens_hsa05152 | 0.45913536 |
| 130 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45766591 |
| 131 | Alcoholism_Homo sapiens_hsa05034 | 0.45081760 |
| 132 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.45051527 |
| 133 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44982037 |
| 134 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44918691 |
| 135 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.44247621 |
| 136 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43637672 |
| 137 | Histidine metabolism_Homo sapiens_hsa00340 | 0.40218746 |
| 138 | Colorectal cancer_Homo sapiens_hsa05210 | 0.40077844 |
| 139 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.38770988 |
| 140 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35521686 |
| 141 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34615642 |
| 142 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33975519 |
| 143 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.31975308 |
| 144 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31503573 |
| 145 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31482846 |
| 146 | Endometrial cancer_Homo sapiens_hsa05213 | 0.29120096 |
| 147 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.27494729 |
| 148 | Endocytosis_Homo sapiens_hsa04144 | 0.26434113 |

